Dexcom (DXCM) Interest Expenses (2010 - 2026)

Dexcom (DXCM) has 17 years of Interest Expenses data on file, last reported at $3.1 million in Q1 2026.

• On a quarterly basis, Interest Expenses fell 34.04% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $3.1 million, a 34.04% decrease from a year earlier, with the FY2025 full-year figure at $160.7 million, down 27.58% from the prior year.
• Interest Expenses for Q1 2026 stood at $3.1 million, down from $17.4 million in the prior quarter.
• Over the last five years, Interest Expenses for DXCM reached as high as $21.7 million in Q4 2024 and fell as low as $1.8 million in Q3 2023.
• Historically, Interest Expenses has averaged $9.8 million across 5 years, with a median of $8.9 million in 2022.
• Across the five-year window, Interest Expenses tumbled 63.27% in 2023 and soared 683.33% in 2024, its largest moves.
• Year by year, Interest Expenses stood at $12.1 million in 2022, then soared by 74.38% to $21.1 million in 2023, then rose by 2.84% to $21.7 million in 2024, then decreased by 19.82% to $17.4 million in 2025, then plunged by 82.18% to $3.1 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $3.1 million in Q1 2026, $17.4 million in Q4 2025, and $14.1 million in Q3 2025.